Physician

Abhishek Singh, M.D., PHD

According to 2025 Medicare claims, Abhishek Singh, M.D., PHD (NPI: 1790010874) practices advanced heart failure and transplant cardiology in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is PRACTICE ASSOCIATES MEDICAL GROUP (NPI: 1427016385; TIN: 202088165) and primary practice location at 07960-6136. Singh is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 416 traditional Medicare patients, billed 1,053 HCPCS/CPT codes, and received $112,896 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,661 prescription claims across 313 beneficiaries totaling $11,386,371 in drug costs, led by Vyndamax (Tafamidis). DME data shows 2,528 claims. Open Payments data shows 205 records totaling $127,134. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $10,690 to $112,896. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,710 to $11,386,371. For DME billing, reported payments moved sharply higher in recent years, from $36,014 to $121,079.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	61	63	$10,690
2016	128	348	$22,110
2017	551	1,721	$122,427
2018	457	1,834	$121,003
2019	494	1,849	$133,555
2020	458	1,308	$102,373
2021	359	1,176	$112,512
2022	442	1,412	$149,065
2023	421	1,166	$124,408
2024	416	1,053	$112,896

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	14	37	$2,710
2016	37	157	$7,706
2017	134	839	$334,880
2018	205	1,660	$578,999
2019	250	1,917	$852,569
2020	288	2,417	$1,607,781
2021	274	1,018	$1,747,415
2022	299	1,371	$3,401,233
2023	296	1,558	$6,240,423
2024	313	1,661	$11,386,371

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	177	$41,578
2018	N/R	129	$253,098
2019	N/R	45	$201,524
2020	N/R	71	$233,037
2021	85	1,103	$302,871
2022	108	1,948	$530,996
2023	159	1,890	$1,677,919
2024	124	2,528	$2,008,643

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	72	76	$144
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	197	241	$144
93451	Insertion of tube in right heart chambers for measurement	81	87	$104
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	135	437	$100
94621	Test for exercise-induced heart and lung stress	44	44	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	251	7,770	$6,044,170
Tyvaso Dpi	Treprostinil	120	3,360	$2,797,342
Opsumit	Macitentan	87	2,610	$1,126,160
Adempas	Riociguat	50	1,500	$695,363
Orenitram Er	Treprostinil Diolamine	55	1,256	$246,300

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7686	Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg	N	N/R	71	$1,147,964
J3285	Injection, treprostinil, 1 mg	N	N/R	114	$700,239
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	35	736	$68,840
J2260	Injection, milrinone lactate, 5 mg	N	30	667	$39,431
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	25	108	$21,207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	178	$53,963	United Therapeutics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	27	$73,171	Morristown Medical Center
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhishek Singh, M.D., PHD?

Tedicare shows public-source Medicare data for Abhishek Singh, M.D., PHD (NPI 1790010874), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhishek Singh, M.D., PHD have ACO affiliation data?

Abhishek Singh, M.D., PHD is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Abhishek Singh, M.D., PHD?

Abhishek Singh, M.D., PHD is linked to PRACTICE ASSOCIATES MEDICAL GROUP (billing NPI 1427016385) in the available physician profile data.

Does Abhishek Singh, M.D., PHD have Open Payments data?

Abhishek Singh, M.D., PHD has 205 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.